Holen Sie sich die Stockscreener-App
896.53
3.90%
33.67
Handel nachbörslich:
892.40
-4.13
-0.46%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LLY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Lilly Eli Co Aktie (LLY) Neueste Nachrichten
Eli Lilly to invest $3B in Dutch manufacturing hub - Silicon Canals
US pharma giant Eli Lilly to build factory in the Netherlands - medwatch.com
Eli Lilly calls on Europe to ditch clawback taxes on drugmakers - Financial Times
Pharmaceutical Giant Eli Lilly Soars on Blockbuster Drug Performance - AD HOC NEWS
Major Shareholder Cashes Out Big on Eli Lilly Stock! - TipRanks
Eli Lilly and Company (NYSE:LLY) Trading 3.9% Higher on Analyst Upgrade - MarketBeat
Lilly Endowment sells $260m in Eli Lilly shares - Investing.com
Next phase of Eli Lilly's plans in Kenosha County take shape - The Business Journals
Eli Lilly announces Q3 results, $3 billion new site, plans for oral GLP-1 approval - drugdiscoverytrends.com
Eli Lilly (LLY) to Build $3 Billion European Plant to Manufacture Weight-Loss Pill - TipRanks
Eli Lilly eyeing Philadelphia for Gateway Labs site, sources say - The Business Journals
BMO Capital Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $930 - 富途牛牛
Tech rules Monday's stock market — plus, Eli Lilly's big comeback and new vote of confidence - CNBC
AstraZeneca, Merck, Eli Lilly to invest $120M in Virginia pharma manufacturing training center - The Business Journals
What's Up With The Rise In Eli Lilly Stock Today? - Benzinga
Eli Lilly to invest €2.7 billion in new factory near Leiden - DutchNews.nl
Lilly earmarks $3B for new European obesity pill factory - Endpoints News
Lilly Announces $1.2B Puerto Rico Expansion, Adding 100 Jobs - InkFreeNews.com
Eli Lilly to Invest $3 Billion in Netherlands Manufacturing Facility for Expanding Medicine Access - geneonline.com
Lilly to build $3 billion Dutch plant to boost weight-loss pill production - Reuters
Eli Lilly’s New Study on Brenipatide: A Potential Game-Changer in Smoking Cessation - TipRanks
Lilly Reveals Plan for New $3 Billion Manufacturing Facility in the Netherlands - Pharmaceutical Commerce
Eli Lilly to build $3B manufacturing site in Netherlands - Inside INdiana Business
Eli Lilly Starting to Tap Into International GLP-1 Demand -- Market Talk - 富途牛牛
$3 Billion Netherlands Plant Part of Lilly’s Global Weight-Loss Push - WIBC 93.1 FM
Eli Lilly building new $3 billion manufacturing facility in Netherlands - WTHR
Eli Lilly (LLY) Invests $3B in Dutch Facility for Obesity Drug P - GuruFocus
Eli Lilly to invest in a $3B manufacturing facility in Netherlands - MSN
Eli Lilly: $3bn investment in new plant in Netherlands - MarketScreener
Lilly's global manufacturing blitz rolls on with $3B plant in Netherlands, plans for 500 hires - Fierce Pharma
American pharmaceutical giant to build $3 billion factory in Katwijk, creating 500 jobs - NL Times
Eli Lilly (LLY) to Invest $3 Billion in Dutch Manufacturing Faci - GuruFocus
Lilly to build $3 billion plant in the Netherlands to boost weight-loss pill production - Latest news from Azerbaijan
Lilly to build $3 billion oral medicine facility in Netherlands - Investing.com
Eli Lilly to build new $3 billion manufacturing facility in Katwijk, the Netherlands - MarketScreener
Eli Lilly Plans to Construct $3 Billion Production Site in Katwijk, Netherlands - MarketScreener
Lilly to build $3B production facility in Netherlands - breakingthenews.net
Eli Lilly to build new $3B facility in Katwijk, the Netherlands - TipRanks
Bernstein reiterates Eli Lilly stock rating at Outperform after strong Q3 - Investing.com Nigeria
Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide - PR Newswire
2 Healthcare Stocks for Individual Investors With a 30-Year Time Horizon - The Motley Fool
Uline, Eli Lilly strive to build talent in Racine, Kenosha area - The Business Journals
HSBC Adjusts Price Target on Eli Lilly and Co. to $850 From $800, Maintains Hold Rating - MarketScreener
Prediction: The Next Eli Lilly Might Already Be Trading Under $50 - AOL.com
Eli Lilly’s Meteoric Rise Fueled by Blockbuster Drugs - AD HOC NEWS
Jim Cramer Admits Surprise at Eli Lilly’s Rally After Strong GLP-1 Results - MSN
Cantor Fitzgerald Reaffirms Price Target on Eli Lilly (LLY) Despite GLP-1 Setback - MSN
Eli Lilly (LLY) Surges on Strong Q3 Results and Upgraded 2025 Ou - GuruFocus
Why The Story Around Eli Lilly Is Evolving After Recent Analyst Updates and Company News - Yahoo! Finance UK
Eli Lilly and Company Beat Revenue Forecasts By 9.5%: Here's What Analysts Are Forecasting Next - Yahoo Finance
Eli Lilly and Company $LLY Shares Acquired by Tredje AP fonden - MarketBeat
Eli Lilly to invest $1.2 billion in Puerto Rico as part of US manufacturing push - ETPharma.com
A Look at Eli Lilly’s (LLY) Valuation After Strong Q3 Earnings, Upbeat Guidance, and Zepbound Expansion Plans - simplywall.st
Eli Lilly (LLY) Would Be Up More If The Market Weren’t That Bad, Says Jim Cramer - MSN
Eli Lilly To Invest Over $1.2 Billion In Puerto Rico Expansion To Boost U.S. Oral Medicine Manufacturing - Pulse 2.0
A Quick Look at Today's Ratings for Eli Lilly and Co(LLY.US), With a Forecast Between $976 to $1,069 - 富途牛牛
Why Eli Lilly Stock Rose Almost 5% Last Week? - TIKR.com
S&P 500 Giants JPMorgan, Eli Lilly Lead Five Stocks Near Buy Points - Investor's Business Daily
Eli Lilly Reports Strong Q3 2025 Growth - The Globe and Mail
Eli Lilly’s Earnings Call: Robust Growth and Strategic Wins - TipRanks
AstraZeneca, Eli Lilly, Merck commit $120M to Virginia pharma training - Virginia Business
Eli Lilly and Company (NYSE:LLY) Trading 2.2% Higher on Strong Earnings - MarketBeat
Evaluating Eli Lilly (LLY): Is the Pharma Giant’s Recent Growth Reflected in Its Current Valuation? - Yahoo Finance
Eli Lilly (LLY) Says Weight-Loss Pill a Candidate for Fast-Track Approval - TipRanks
1.38%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):